[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.73.72. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1958

Penetration of Pyrimethamine (Daraprim) into Ocular Tissues of Rabbits

Author Affiliations

Seoul, Korea
Yonsei University, School of Medicine.

AMA Arch Ophthalmol. 1958;60(4):603-611. doi:10.1001/archopht.1958.00940080623008
Abstract

Chemically, pyrimethamine (Daraprim) is 2,4-diamino-5-p-chlorophenyl-6-ethylpyrimidine, with the empirical formula C12H13N4Cl. This chemical was synthesized by the Wellcome Research Laboratories, Tuckahoe, N. Y., as an antimalarial drug which arrests plasmodial development at those stages involving nuclear division. Besides this antimalarial activity, pyrimethamine has been shown to have an extraordinarily potent antimetabolite activity.

To my limited knowledge, the mode of action of the preparation against toxoplasmosis has not been entirely elucidated. However, Eyles and his associate,1 in 1952, reported antitoxoplasminic action of the drug in mice and, in 1953, showed that pyrimethamine and sulfadiazine were synergistic to each other against experimental toxoplasmosis in the mouse.2 Since these reports, the drug has been widely used in the treatment of presumptive toxoplasmic infections of man as well as of experimental toxoplasmosis of animals.

In the past years, numerous papers on the subject have been published, creating

×